Two human cathepsin proteins
CA 2264546 A1 · Owner: Coleman, Roger · Inventors: Coleman, Roger; Bandman, Olga
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides two novel human cathepsin proteins (HCPs) and polynucleotides encoding HCPs. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding HCPs. The invention also provides for the production and use of antibodies to HCPs in pharmaceutical compositions for the treatment of disease processes that include cancers inflammation, metastasis and peptide , and proenzyme processing. In addition the invention provides for the , production and use of inhibitors of HCPs in pharmaceutical compositions for the treatment of diseases. The invention also describes diagnostic assays which utilize the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 25, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 25, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 25, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.